This Article Free upon publication Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Related Collections Related Articles

(Circulation. 2007;116:879.)
© 2007 American Heart Association, Inc.

Issue Highlights

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	INDEPENDENT IMPACT OF GOUT ON MORTALITY AND RISK FOR CORONARY HEART DISEASE, by Choi and Curhan.

 
Gout is the most common inflammatory arthritis in men, yet data on the impact of gout on risk of death and cardiovascular disease are limited. Prior studies have investigated the risks associated with hyperuricemia but have not focused specifically on long-term outcomes in patients with clinical gout. In this issue of Circulation, Choi and Curhan describe prospective data about the impact of gout on risk of death in the >51 000 male participants of the Health Professionals Follow-Up Study. The authors note that over a follow-up period of 12 years, men with gout had a 28% higher risk of death from all causes than men without prior coronary heart disease (CHD) or gout. Among men without preexisting CHD, the increased mortality risk was due to elevated risk of cardiovascular disease deaths, particularly CHD deaths. These associations were independent of established risk factors, including age, body mass index, smoking, family history of myocardial infarction, use of diuretics and aspirin, dietary risk factors, diabetes, hypercholesterolemia, and hypertension. These observational data support aggressive management of cardiovascular risk factors, including hypertension, dyslipidemia, and lifestyle factors, in patients with gout. See p 894 (editorial p 880).

	SERIAL ANGIOSCOPIC EVIDENCE OF INCOMPLETE NEOINTIMAL COVERAGE AFTER SIROLIMUS-ELUTING STENT IMPLANTATION: COMPARISON WITH BARE-METAL STENTS, by Awata et al.

 
Neointimal coverage after implantation of drug-eluting stents is recognized to be delayed as compared with bare-metal stents. Serial angioscopy allows assessment of neointimal formation and subclinical thrombosis after drug-eluting stent implantation. In the study in this issue by Awata et al, angioscopy was performed serially at 3.6±1.1 months, 10.5±1.5 months, and 21.2±2.2 months after implantation in 17 . . . [Full Text of this Article]

Related Articles:

Podagra, Uric Acid, and Cardiovascular Disease

Michael H. Alderman
Circulation 2007 116: 880-883. [Extract] [Full Text]

Pseudomitral Intraventricular Valve

Jesús Peteiro, Beatriz Bouzas, Rafaela Soler, and Agustin Perez-Gomez
Circulation 2007 116: e306-e307. [Extract] [Full Text]

Papillary Muscle Infarction After Cardiopulmonary Resuscitation

Pier Giorgio Masci, Steven Dymarkowski, and Jan Bogaert
Circulation 2007 116: e308-e309. [Extract] [Full Text]

Letter by Wetzels Regarding Article, "Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A Randomized Comparison of 3 Preventive Strategies"

Jack F.M. Wetzels
Circulation 2007 116: e310. [Extract] [Full Text]

Serial Angioscopic Evidence of Incomplete Neointimal Coverage After Sirolimus-Eluting Stent Implantation: Comparison With Bare-Metal Stents

Masaki Awata, Jun-ichi Kotani, Masaaki Uematsu, Takakazu Morozumi, Tetsuya Watanabe, Toshinari Onishi, Osamu Iida, Fusako Sera, Shinsuke Nanto, Masatsugu Hori, and Seiki Nagata
Circulation 2007 116: 910-916. [Abstract] [Full Text]

Aortic Arch Atheroma Progression and Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack

Souvik Sen, Alan Hinderliter, Pranab K. Sen, Jennifer Simmons, James Beck, Steven Offenbacher, E. Magnus Ohman, and Stephen M. Oppenheimer
Circulation 2007 116: 928-935. [Abstract] [Full Text]